unknown
Stage
2010
Founded
1
Investors
About
Chiasma is a biopharmaceutical company focused on developing and commercializing oral peptide therapies for the treatment of rare diseases.
Explore chiasma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.